Ovid Therapeutics Inc
|Market Cap (Intraday)||236.59M|
|2yr Forward PE||N/A|
Ovid Therapeutics Inc Stock, NASDAQ:OVID
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.